• June 3-6, 2024
  • San Diego Convention Center, California

Sessions

Loading

Forge Biologics

Tuesday, June 04, 2024
Company Presentation Theater 4
Forge Biologics, a member of Ajinomoto Biopharma Services, is a hybrid gene therapy contract manufacturing and clinical-stage therapeutics development company enabling access to life-changing gene therapies by bringing them from concept to reality. Forge’s 200,000 square foot facility, the Hearth, is headquartered in Columbus, Ohio, and houses 20 custom-designed cGMP suites. Forge’s end-to-end, scalable plasmid and AAV manufacturing services include research-grade manufacturing, process and analytical development, cGMP manufacturing, fill and finish, and regulatory consulting support to help accelerate the timelines of transformative medicines for patients with genetic diseases. To learn more, visit www.forgebiologics.com.
Forge Biologics
Company Website: https://www.forgebiologics.com/
Lead Product in Development: FBX-101, an AAV gene therapy for patients with Krabbe disease
Number Of Unlicensed Products (For Which You Are Seeking Partners): n/a

Exchange

The Tokyo Stock Exchange / TYO

Ticker

AJINY

Company HQ City

Grove City

Company HQ State

Ohio

Company HQ Country

United States

CEO/Top Company Official

Timothy J. Miller

Development Phase of Primary Product

Phase I
Primary Speaker
Taleen Barsoumian
Vice President
Forge Biologics
Back to Session List

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS